Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 109

1.

Curcumin inhibits the migration and invasion of human A549 lung cancer cells through the inhibition of matrix metalloproteinase-2 and -9 and Vascular Endothelial Growth Factor (VEGF).

Lin SS, Lai KC, Hsu SC, Yang JS, Kuo CL, Lin JP, Ma YS, Wu CC, Chung JG.

Cancer Lett. 2009 Nov 28;285(2):127-33. doi: 10.1016/j.canlet.2009.04.037. Epub 2009 May 23.

PMID:
19477063
2.

Curcumin inhibits proliferation, invasion, angiogenesis and metastasis of different cancers through interaction with multiple cell signaling proteins.

Kunnumakkara AB, Anand P, Aggarwal BB.

Cancer Lett. 2008 Oct 8;269(2):199-225. doi: 10.1016/j.canlet.2008.03.009. Epub 2008 May 13. Review.

PMID:
18479807
3.

[Matrix metalloproteinases and colorectal cancer].

Roeb E, Matern S.

Med Klin (Munich). 2003 Dec 15;98(12):763-70. Review. German.

PMID:
14685678
4.

Thymosin beta4 regulates migration of colon cancer cells by a pathway involving interaction with Ku80.

Cierniewski CS, Papiewska-Pajak I, Malinowski M, Sacewicz-Hofman I, Wiktorska M, Kryczka J, Wysocki T, Niewiarowska J, Bednarek R.

Ann N Y Acad Sci. 2010 Apr;1194:60-71. doi: 10.1111/j.1749-6632.2010.05480.x. Review.

PMID:
20536451
5.

Antitumor, anti-invasion, and antimetastatic effects of curcumin.

Kuttan G, Kumar KB, Guruvayoorappan C, Kuttan R.

Adv Exp Med Biol. 2007;595:173-84. Review.

PMID:
17569210
6.

Matrix metalloproteinases in tumor invasion: role for cell migration.

Nabeshima K, Inoue T, Shimao Y, Sameshima T.

Pathol Int. 2002 Apr;52(4):255-64. Review.

PMID:
12031080
7.

Matrix metalloproteinase inhibitors: do they have a place in anticancer therapy?

Rudek MA, Venitz J, Figg WD.

Pharmacotherapy. 2002 Jun;22(6):705-20. Review.

PMID:
12066962
8.

[The role of matrix metalloproteinases in the pathogenesis of diabetes mellitus and progression of diabetes retinopathy].

Naduk-Kik J, Hrabec E.

Postepy Hig Med Dosw (Online). 2008 Sep 3;62:442-50. Review. Polish.

9.

Anticancer and carcinogenic properties of curcumin: considerations for its clinical development as a cancer chemopreventive and chemotherapeutic agent.

López-Lázaro M.

Mol Nutr Food Res. 2008 Jun;52 Suppl 1:S103-27. doi: 10.1002/mnfr.200700238. Review.

PMID:
18496811
10.

Matrix metalloproteinases and matrix metalloproteinase inhibitors in lung cancer.

Bonomi P.

Semin Oncol. 2002 Feb;29(1 Suppl 4):78-86. Review.

PMID:
11894017
11.

Trypsin in colorectal cancer: molecular biological mechanisms of proliferation, invasion, and metastasis.

Soreide K, Janssen EA, Körner H, Baak JP.

J Pathol. 2006 Jun;209(2):147-56. Review.

PMID:
16691544
12.

Curcumin as an inhibitor of angiogenesis.

Bhandarkar SS, Arbiser JL.

Adv Exp Med Biol. 2007;595:185-95. Review.

PMID:
17569211
13.

Molecular insights into cancer invasion: strategies for prevention and intervention.

Kohn EC, Liotta LA.

Cancer Res. 1995 May 1;55(9):1856-62. Review.

14.

Gelatinase-mediated migration and invasion of cancer cells.

Björklund M, Koivunen E.

Biochim Biophys Acta. 2005 May 25;1755(1):37-69. Epub 2005 Apr 12. Review.

PMID:
15907591
15.

Uterine cervical carcinoma: role of matrix metalloproteinases (review).

Libra M, Scalisi A, Vella N, Clementi S, Sorio R, Stivala F, Spandidos DA, Mazzarino C.

Int J Oncol. 2009 Apr;34(4):897-903. Review.

PMID:
19287946
16.

Biological effects of curcumin and its role in cancer chemoprevention and therapy.

Singh S, Khar A.

Anticancer Agents Med Chem. 2006 May;6(3):259-70. Review.

PMID:
16712454
17.

Curcumin and cancer: an "old-age" disease with an "age-old" solution.

Anand P, Sundaram C, Jhurani S, Kunnumakkara AB, Aggarwal BB.

Cancer Lett. 2008 Aug 18;267(1):133-64. doi: 10.1016/j.canlet.2008.03.025. Epub 2008 May 6. Review.

PMID:
18462866
18.

Matrix metalloproteinases stimulate epithelial-mesenchymal transition during tumor development.

Orlichenko LS, Radisky DC.

Clin Exp Metastasis. 2008;25(6):593-600. doi: 10.1007/s10585-008-9143-9. Epub 2008 Feb 20. Review.

PMID:
18286378
19.

Angiotensin converting enzyme inhibitors for cancer treatment?

Lindberg H, Nielsen D, Jensen BV, Eriksen J, Skovsgaard T.

Acta Oncol. 2004;43(2):142-52. Review.

PMID:
15163162
20.

The other side of MMPs: protective roles in tumor progression.

Martin MD, Matrisian LM.

Cancer Metastasis Rev. 2007 Dec;26(3-4):717-24. Review.

PMID:
17717634
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk